All stocks Β· AGARWALEYE
DA

Dr. Agarwal's Health Care Limited

AGARWALEYE BSE Medical Instruments & Supplies Healthcare

Dr. Agarwal's Health Care Limited engages in running, owning, and managing eye care hospitals, opticals, pharmacies, etc. and related services in India and internationally. It offers femto cataracts, lenticular procedur…

ISIN INE943P01029
Listed β€”
Quarters tracked 11
Filings 6 docs

About

Dr. Agarwal's Health Care Limited engages in running, owning, and managing eye care hospitals, opticals, pharmacies, etc. and related services in India and internationally. It offers femto cataracts, lenticular procedure, retinal surgeries, anterior segment reconstruction, and corneal transplants, as well as refractive and other surgeries. The company also develops, designs, manufactures, imports, and exports healthcare devices, which include ophthalmic diagnostic devices, such as auto perimeter, optical biometers, and ophthalmoscopes. In addition, the company offers consultations, diagnoses, and non-surgical treatments; and sells opticals, contact lenses and accessories, and eye care related pharmaceutical products. Dr. Agarwal's Health Care Limited was incorporated in 2010 and is based in Chennai, India.

Key Metrics

as of Sep 2026
Market Cap16,298 Cr
P/E110.00
Div Yield0.00 %
Book Valueβ‚Ή63.90
52w Highβ‚Ή568.00
52w Lowβ‚Ή401.00
Face Valueβ‚Ή1.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023
Sales 383.00 348.00 335.00 309.00 302.00 281.00 268.00 255.00 240.00 225.00 213.00
Expenses 287.00 256.00 255.00 240.00 235.00 208.00 203.00 198.00 190.00 157.00 158.00
Operating Profit 96.00 92.00 80.00 69.00 67.00 73.00 65.00 58.00 49.00 67.00 55.00
OPM % 25.00 26.00 24.00 22.00 22.00 26.00 24.00 23.00 21.00 30.00 26.00
Other Income 3.00 1.00 6.00 6.00 12.00 24.00 10.00 5.00 2.00 13.00 13.00
Depreciation 58.00 56.00 48.00 48.00 44.00 42.00 39.00 38.00 37.00 35.00 32.00
Interest 19.00 19.00 18.00 17.00 19.00 21.00 23.00 23.00 23.00 22.00 22.00
Profit before tax 22.00 18.00 20.00 10.00 16.00 34.00 12.00 1.00 -8.00 24.00 15.00
Tax % 26.00 42.00 31.00 51.00 35.00 22.00 37.00 746.00 5.00 29.00 37.00
Net Profit 17.00 11.00 14.00 5.00 10.00 27.00 8.00 -4.00 -9.00 17.00 10.00
EPS in Rs 0.53 0.33 0.44 0.15 0.32 0.84 0.25 β€” β€” β€” β€”

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Sales 1,293.001,044.00835.00598.00362.00232.00248.00202.00
Expenses 986.00795.00611.00436.00275.00199.00202.00186.00
Operating Profit 308.00249.00224.00162.0086.0033.0046.0016.00
OPM % 24.0024.0027.0027.0024.0014.0019.008.00
Other Income 26.0040.0038.00-12.0010.004.009.005.00
Interest 73.0094.0088.0064.0038.0034.0042.0020.00
Depreciation 197.00156.00129.0092.0059.0055.0049.0021.00
Profit before tax 64.0039.0045.00-6.00-1.00-52.00-36.00-20.00
Tax % 38.0043.0047.00-641.0055.004.000.000.00
Net Profit 39.0022.0024.0032.00-1.00-54.00-36.00-20.00
EPS in Rs 1.250.69β€”β€”β€”β€”β€”β€”
Dividend Payout % 0.000.000.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Equity Capital 32.0032.009.008.007.007.007.007.00
Reserves 1,960.001,902.001,218.00554.00192.00194.00248.00290.00
Borrowings 670.00568.00661.00590.00252.00161.00142.00135.00
Other Liabilities 300.00335.00298.00236.00242.00281.00200.0060.00
Total Liabilities 2,961.002,837.002,187.001,388.00692.00643.00596.00492.00
Fixed Assets 1,922.001,591.001,302.00907.00367.00387.00322.0099.00
CWIP 29.0018.009.0035.002.0011.003.001.00
Investments 615.00729.00629.00187.00147.00121.00146.00238.00
Other Assets 395.00498.00248.00258.00176.00124.00124.00154.00
Total Assets 2,961.002,837.002,187.001,388.00692.00643.00596.00492.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Cash from Operating Activity 321.00208.00222.00153.0078.0046.0040.00
Cash from Investing Activity -167.00-577.00-818.00-436.00-98.00-26.00-37.00
Cash from Financing Activity -173.00374.00570.00316.0040.00-21.00-60.00
Net Cash Flow -19.005.00-26.0033.0020.00-1.00-56.00
Free Cash Flow 6.0018.0087.0076.0012.0023.00-91.00
CFO/OP % 115.0081.00105.00102.0094.00147.0094.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debtor Days 23.0025.0022.0024.0031.0039.0046.0046.00
Inventory Days 66.00174.00135.00119.00149.00147.00159.00138.00
Days Payable 122.00375.00383.00354.00456.00608.00427.00330.00
Cash Conversion Cycle -32.00-176.00-226.00-210.00-276.00-422.00-222.00-147.00
Working Capital Days -21.00-55.00-79.00-88.00-54.00-43.00-37.005.00
ROCE % 6.006.008.0010.009.00-5.001.00β€”

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025
Promoters 32.34 32.35 32.39 32.43 32.43 32.45
FIIs 57.97 57.94 58.06 58.13 59.26 60.62
DIIs 7.72 7.83 7.78 7.92 6.44 5.21
Public 1.97 1.87 1.78 1.52 1.87 1.74
No. of Shareholders 42,492 43,538 46,554 48,168 63,021 68,696

Corporate Actions

No corporate actions recorded.

Announcements

5 filings

Shareholding Pattern

Open on BSE

Financial Results β€” Filings

Open on BSE

Board Filings

Open on BSE

Annual Reports

Credit Ratings

Conference Calls